2025 was another eventful year for cannabis worldwide, marked by the continued rollout of European reforms, shifting policies across Asia, the ongoing maturation and challenges of the global industry, and the slow evolution of international frameworks — a year that reflected both the momentum of the global shift away from prohibition and the real obstacles and complexities that remain.
A year of continued change
2025 saw the ongoing evolution of cannabis policy and industry worldwide, continuing the broader global shift away from strict prohibition while highlighting the complexities and challenges involved. The year featured developments across multiple regions and dimensions. Reviewing 2025 reveals a landscape in continued transition, where reform momentum persisted alongside significant obstacles, reflecting the uneven, gradual and multifaceted nature of the global movement to reconsider and reshape cannabis policy and markets.
Europe’s reforms roll out
In Europe, 2025 saw the continued rollout and development of reforms, including Germany’s cannabis clubs and home-growing framework maturing, Switzerland’s pilot programs advancing, the Netherlands’ supply experiment progressing, and ongoing debates in countries like the Czech Republic. European reform remained a central theme. The gradual implementation of European reforms throughout the year illustrated both the progress and the challenges of the continent’s cautious, treaty-compatible approach to cannabis liberalization.
Germany’s clubs mature
Germany’s landmark reform continued to develop, with cannabis clubs slowly rolling out amid uneven state-by-state licensing, home growing becoming established, and the commercial pillar remaining stalled. Germany’s experience was closely watched as a test case. The maturation of Germany’s reform, with its successes and unresolved issues, exemplified the practical realities of implementing cannabis legalization in a major economy, and its progress and challenges informed the broader European conversation about reform.
Asia’s shifting policies
Asia presented dynamic developments, with Thailand’s continued shift back toward medical-only cannabis after its earlier decriminalization, alongside the region’s generally strict prohibition and cautious debates elsewhere. Asian policy remained a significant and volatile area. The shifting policies in Asia, particularly Thailand’s ongoing recalibration, highlighted the challenges of cannabis reform in the region and the contrast between experimentation and the prevailing prohibitionist stance across much of the continent.
Thailand’s ongoing recalibration
Thailand’s efforts to rein in its cannabis market toward medical-only use continued to create uncertainty for the industry that emerged after 2022, remaining a prominent example of the challenges of poorly sequenced reform. Thailand’s situation stayed in focus throughout the year. The ongoing recalibration in Thailand served as a continuing cautionary tale about the difficulties of managing cannabis liberalization without a stable legal framework, influencing regional and global discussions about how to reform responsibly.
The industry’s challenges
The global cannabis industry continued to face challenges in 2025, including market maturation, consolidation, competition, pricing pressures and the persistent difficulty of displacing illicit markets, as the sector moved beyond its earlier speculative phase. Industry realities remained a key theme. The ongoing challenges facing the cannabis industry throughout the year reflected its maturation into an established but demanding sector, where profitability and sustainable business models required navigating significant obstacles.
Emerging producers advance
Emerging cannabis-producing regions in Africa, Latin America and elsewhere continued to develop their industries in 2025, pursuing export opportunities while facing competition and market-access challenges. The growth of these producers remained a notable global trend. The continued advance of emerging producers throughout the year reflected the ongoing globalization of cannabis cultivation and the efforts of countries seeking economic benefit from supplying the international market, even amid competitive and practical difficulties.
International frameworks evolve
The international cannabis framework continued its slow evolution in 2025, shaped by the earlier reclassification recognizing medical value and the growing number of countries pushing boundaries, though the treaties remained in place. The gradual shift of the international system persisted. The ongoing, incremental evolution of international frameworks throughout the year reflected the tension between longstanding treaties and proliferating national reforms, a dynamic central to the future trajectory of global cannabis policy.
Medical cannabis expands
Medical cannabis access continued to expand globally in 2025, with growing patient numbers and new or developing programs in various countries, remaining a primary driver of the broader liberalization trend. Medical expansion was a consistent theme. The continued growth of medical cannabis throughout the year underscored its role as the leading edge of reform, building acceptance and infrastructure and reflecting the increasing recognition of cannabis as a legitimate therapeutic option across many parts of the world.
Persistent obstacles
Despite the momentum, 2025 also highlighted persistent obstacles to reform and industry success, including political resistance in many countries, the resilience of illicit markets, regulatory challenges and the complexities of implementation. These obstacles tempered the year’s progress. The persistence of significant challenges throughout the year served as a reminder that the global cannabis shift, while real, remains uneven, contested and complicated, with substantial work required to realize the goals of reform and build sustainable legal markets.
The bigger picture
Viewed broadly, 2025 reflected the continued, uneven global movement away from strict cannabis prohibition, with progress in reform and medical access alongside real challenges and regional variation. The year fit within the longer arc of changing cannabis policy. The bigger picture emerging from 2025 was one of ongoing transformation, in which the world continued to reconsider cannabis at different paces and in different ways, moving gradually toward a more diverse and reform-oriented global landscape while grappling with enduring complexities.
The bottom line
2025 was another eventful year for cannabis worldwide, marked by the continued rollout of European reforms, shifting Asian policies, the maturation and challenges of the global industry, expanding medical access, and the slow evolution of international frameworks. The year reflected both the momentum of the global shift away from prohibition and the persistent obstacles that remain, capturing the uneven, complex and ongoing transformation of cannabis policy and markets across the world.
Legalization status by the numbers
- Europe: Reforms rolling out: Germany’s clubs, Switzerland’s pilots, Netherlands’ supply trial, Czech debate
- Asia: Thailand shifting back toward medical-only; region largely prohibitionist
- Industry: Continued maturation, consolidation and illicit-market competition
- Emerging producers: Africa and Latin America advancing export-focused cultivation
- International: Frameworks slowly evolving after medical-value reclassification
Related coverage on Weedly
- Cannabis Legalization Public Health Evidence
- Cannabis Legalization Youth Use Evidence
- Israel Pioneer Medical Cannabis Research
- Where Is Medical Cannabis Legal 2025
- Japans New Cbd Legislation Upholding Firm Thc Limits


